Leukemia Drug in High Dose Helps Survival Sep 25, 2009
Two research teams -- the U.S.-based Eastern Cooperative Oncology Group (ECOG) and a team of scientists in the Netherlands, Belgium, Germany and Switzerland -- studied almost 1,500 patients and independently reported higher rates of complete remission and overall survival in those who received high doses of the chemo drug daunorubicin, compared to those who receive the standard dose ... The two research teams set out to determine whether that was actually the case -- in patients younger than age... (MEDLINEplus)
Reading the brain without poking it Jun 29, 2009
The new kind of array is called a microECoG because it involves tiny or "micro" versions of the much larger electrodes used for electrocorticography, or ECoG, developed a half century ago ... For patients with severe epileptic seizures that are not controlled by medication, surgeons remove part of the skull or cranium and place a silicone mat containing ECoG electrodes over the brain for days to weeks while the cranium is held in place but not reattached ... ECoG and microECoG represent an... (EurekAlert!)
Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting May 15, 2009
Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and ECOG Performance Status on Outcome in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: Analysis of Two Phase 3, Randomized Double-Blind Trials. Jordi Bruix, M.D., Director, BCLC Group, Liver Unit, Hospital Clinic, University of Barcelona, Spain. (PR Newswire)
Study shows that maintenance rituximab is useful for advanced indolent lymphoma Mar 11, 2009
In a study, sponsored by the National Institutes of Health and conducted by the Eastern Cooperative Oncology Group (ECOG) titled, "Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study," researchers looked at 311 patients with stable or responding disease after CVP therapy ... The National Cancer Institute funded this multi-center, national trial through ECOG,... (EurekAlert!)
Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients Feb 7, 2009
Both groups had similar frequencies of serious treatment-related toxicity, according to the study, conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG). "The findings of this large clinical trial are important, because they will likely change practice and improve the outcome for many patients with AML," Dr. Martin Tallman, chairman of the ECOG leukemia committee and a professor of medicine at Northwestern University Feinberg School of Medicine and the Robert... (MEDLINEplus)
